ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $42,476,000 | +554.3% | 246,814 | +327.8% | 0.03% | +540.0% |
| Q3 2020 | $6,492,000 | +467.0% | 57,691 | +188.5% | 0.01% | +400.0% |
| Q3 2018 | $1,145,000 | -68.6% | 20,000 | -73.4% | 0.00% | -80.0% |
| Q2 2018 | $3,652,000 | +140.9% | 75,248 | +110.7% | 0.01% | +150.0% |
| Q4 2017 | $1,516,000 | -67.6% | 35,712 | -71.5% | 0.00% | -71.4% |
| Q3 2017 | $4,672,000 | +23.3% | 125,208 | +0.4% | 0.01% | 0.0% |
| Q2 2017 | $3,789,000 | – | 124,672 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |